DRAFT PROGRAMME February 17, 2014 09:00 – 16:30 Hrs
09:00 - 16:30 Hrs
08:30 – 16:30 Hrs
Workshop 1 Venture Capital & Private Equity in Life Sciences & Healthcare
Workshop 2 Master Class on Bio-entrepreneurship – Accelerating Innovation to Marketplace
BioPark Visit
17:00 – 18:00 18:30 – 19:30
Inaugural Ceremony Keynote Addresses India’s vision and path to become the Innovation Hub – Opportunities Dr. K. Vijay Raghavan, Secretary to the Government of India, Department of Biotechnology* Global Life Sciences Innovation Landscape – Where are we and what next? Mr. Chris Stirling, Global Head of Life Sciences, KPMG, UK Spurring Innovations - Success story of Flemish Institute of Biotechnology Dr. Johan Cardoen, Managing Director, Flemish Institute of Biotechnology, Belgium
19:30 – 21:00 Gala Reception (Only for registered delegates) February 18, 2014 10:00 – 11:30
Panel Discussion Technology Tracks Creating an Innovation EcoSystem Role of Industry, Academia, Government, Investors and Service Providers, Science Parks and others Chairman: Dr. Ajit Shetty, Corporate Vice President (Global Operations) Retd. and Chairman Emeritus, Janssen Pharmaceutica (J&J), Belgium Panelists: Prof. Seyed E. Hasnain, Director (Bio), IIT Delhi and Member, PM Scientific Advisory Council Dr. TAN Geok Leng, Executive Director (Science and Engineering Research Council), A*STAR, Singapore* Dr. Renu Swaroop, Managing Director, DBT-BIRAC, Government of India Ms. Deepanwita Chattopadhyay, CEO, IKP Knowledge Park* Representative from Imperial College of London/University of Cambridge, UK Moderator – To be identified Session Sponsored by DBT-BIRAC
11:30 – 12:00 12:00 – 13:30
Break Panel Discussion
1. Drug Discovery 2. BioEnergy 3. BioTherapeutics
Exhibition and Partnering
Models for enhancing Lifesciences R&D Efficiencies Collaborative and External R&D, R&D Initiatives that will reduce the cost and time from concept to cure, Partnerships Chair and Keynote Speaker - Dr. Bill Hait, Global Head R&D, Janssen Pharmaceutica (J&J), USA Panelists: Dr. Pankaj Patel, Chairman and MD, Zydus Cadila* Dr. Uwe Schoenbeck, Chief Scientific Officer and Head of External R&D Innovation, Worldwide R&D, Pfizer Dr. Phil Kearney, Director, Licensing and External Research, MSD, Australia Dr. Steve Yang, Asia Head (R&D), AstraZeneca, China* Dr. Subir Basak, President - Global Drug Discovery, Jubilant Lifesciences Moderator – Mr. Utkarsh Palnitkar, National Head of Life Sciences, KPMG, India 13:30 - 15:00 15:00 – 16:30
Lunch Panel Discussion Intellectual Property Regime - Barrier or Incentive? Panelists: Dr. Yusuf Khwaja Hamied, Chairman, Cipla* Dr. Ranjit Shahani, CEO, Novartis India Dr. AKS Bhujanga Rao, President(R&D & Technology), Natco Pharma* Mr. Chaitanya Prasad, IAS, Controller General of Patents, Designs & Trade Marks, India* Mr. Guriqbal Singh Jaiya, Advisor to DDG (Innovation & Technology), World Intellectual Property Organization (WIPO), Switzerland Representative from Japan Patent Office Moderator – To be identified
16:30 – 18:00
Fireside Chat with Indian Health Regulators Officials from Ministry of Health, Govt. of India - Secretary (Shri KN Desiraju)/ Joint Secretary (Dr. Arun Kumar Panda)* Dr. GN Singh, DCGI, Govt. of India* Moderator – Mr. Vikas Dandekar, India Bureau Chief, Elsevier Business Intelligence Coordinated by Pharmexcil
18:30 – 20:00
CEO Conclave (Only by Invitations) Is Innovations a viable business model for India?
Mr. Abbas Hussain, President (MENA) and Executive Board Member, GSK, UK Dr. Glenn Saldhana, CEO, Glenmark Pharmaceuticals Mr. Rehan Khan, MD, Abbott, India Dr. Edgard Olaizola, MD (India and Sri Lanka), Lilly India Dr. GV Prasad, Chairman & CEO, Dr. Reddy’s Laboratories Ltd.* Mr. Aijaz Tobaccowala, MD, Pfizer India*
Moderator – Anchor from CNBC
20:00 – 21:00 CEO Conclave Dinner Reception February 19, 2014 10:30-11:30
Plenary Address Open Innovation and R&D
Technology Tracks
Panelists: 1. Bio-IT Dr. T S Balganesh, Head, Open Source Drug Discovery 2. Medical Initiative, CSIR, Government of India Electronics and Dr. Abhijit Barve, President, R&D, Biocon Ltd.* Devices Dr. Rasmus Rojkjaer, Vice President and Head of Global 3. Regenerative Biologics R&D, Mylan Pharmaceuticals, Switzerland Medicine Dr. Toshiyuki Mori, Director, Alliance Group, Pharmaceutical Research Division, Takeda Pharmaceutical Co. Ltd., Japan Dr. Bapoing Wang, Managing Director, Novo Nordisk, China Representative from Lilly GERD Moderator – To be identified 11:30 – 12:00 12:00 – 13:30
Session Sponsored by Jubilant Life Sciences Break Panel Discussion First-Mover Advantage: The Case for Investing in Life Science Panelists: Dr. Anula Jayasuriya, Co-founder, Evolvence India Life Science Fund, USA Representative from 5 AM Ventures, USA* Mr. Nitin Deshmuk, Kotak PE, India* Mr. Prem Pavoor, Director, Fidelity Capital Partners* Mr. Srinivas Alluri, MD – India (PE), Morgan Stanley* Representative from Amgen Ventures / Merck Ventures* Dr. Anand Anandkumar, CEO, Cellworks*
13:30 - 15:00
Lunch
15:00 – 16:30
Panel Discussion Innovations and the 3A challenges (Accessibility, Affordability and Availability) Chairman: Dr. VM Katoch, Director General, ICMR* Panelists: Smt. Aradhana Johri IAS, Secretary, Department of Pharmaceutical, Government of India* Dr. J Radhakrishnan IAS, Principal Secretary (Health), Government of Tamil Nadu* Dr. Vivek Ahuja, Director, Clinical Research & Development, PATH (Program for Appropriate Technology in Health),India Dr. Cyrus Karkaria, President (Biotech), Lupin Pharma* Dr. Krishna Ella, Chairman and Managing Director, Bharat Biotech Intl. Ltd* Moderator – To be identified
16:30 – 17:30
Valedictory Ceremony and Event Close
*Yet to be confirmed/Invited
Exhibition and Partnering